














Gone are the days of passive check-writing; today's investors are rolling up their sleeves and putting in some elbow grease. From incubating startups to becoming active partners with their portfolio companies, these financial wizards are rewriting the rules of engagement. But what's driving this shift? Is it the allure of long-term impact over quick returns? Or perhaps the realization that healthcare's complex challenges demand more than just capital infusion? As traditional venture models evolve, we're witnessing the birth of true partnerships between investors and innovators. How are they measuring impact beyond dollar signs? There’s a delicate balance between hands-on involvement and entrepreneurial autonomy. From limited partners incentivizing impact to funds becoming de facto co-founders, the startup - investor relationship is getting more serious. Welcome to the world where your next big health tech idea might be born in a VC boardroom.